Israeli Neuroscience Startup Raises Million In Financing

ElMindA, the Israeli pioneer in neuroscience-based technology for analyzing brain network functionality, has announced an oversubscribed $28 million round of Series C financing. The proceeds will be used to continue advancement of ElMindA’s proprietary BNA (Brain Network Activation) system, which uses multi-channel EEG-ERP electrophysiology technology to provide a more accurate, objective assessment of brain functionality over time. BNA is a non-invasive technology for measuring and analyzing brain function. Investors in this new round of funding include the Chinese investment firm Shanda Group, the Swiss company Healthcrest AG, and The Kraft Group, a grouping of companies held by the family of New England Patriots owner Robert Kraft. “We are thrilled to have attracted such a strong group of new and existing investors,” said Ronen Gadot, chief executive officer of ElMindA. “This support is a testament…


Link to Full Article: Israeli Neuroscience Startup Raises Million In Financing